* Expects to report top-line data upon completion of
multiple-dose phase 1 program in q4 of 2016
The post BRIEF-Concert Pharma initiates phase 1 trial of CTP-543 appeared first on NASDAQ.
Forex – financial instrument.Forex news
* Expects to report top-line data upon completion of
multiple-dose phase 1 program in q4 of 2016
The post BRIEF-Concert Pharma initiates phase 1 trial of CTP-543 appeared first on NASDAQ.